Mitoxantrone, etoposide, and cytarabine (MEC) regimen for relapsed or refractory acute myelogenous leukemia

James Waddell, Dominic A. Solimando

Research output: Contribution to journalReview article

Original languageEnglish (US)
Pages (from-to)218-221
Number of pages4
JournalHospital Pharmacy
Volume38
Issue number3
DOIs
StatePublished - Mar 1 2003

Fingerprint

Mitoxantrone
Cytarabine
Etoposide
Refractory materials

All Science Journal Classification (ASJC) codes

  • Pharmacy
  • Pharmacology
  • Pharmacology (medical)

Cite this

Mitoxantrone, etoposide, and cytarabine (MEC) regimen for relapsed or refractory acute myelogenous leukemia. / Waddell, James; Solimando, Dominic A.

In: Hospital Pharmacy, Vol. 38, No. 3, 01.03.2003, p. 218-221.

Research output: Contribution to journalReview article

@article{fa9be0d0b6a147e098e524e6a6a19f81,
title = "Mitoxantrone, etoposide, and cytarabine (MEC) regimen for relapsed or refractory acute myelogenous leukemia",
author = "James Waddell and Solimando, {Dominic A.}",
year = "2003",
month = "3",
day = "1",
doi = "10.1177/001857870303800303",
language = "English (US)",
volume = "38",
pages = "218--221",
journal = "Hospital Pharmacy",
issn = "0018-5787",
publisher = "Facts and Comparisons",
number = "3",

}

TY - JOUR

T1 - Mitoxantrone, etoposide, and cytarabine (MEC) regimen for relapsed or refractory acute myelogenous leukemia

AU - Waddell, James

AU - Solimando, Dominic A.

PY - 2003/3/1

Y1 - 2003/3/1

UR - http://www.scopus.com/inward/record.url?scp=0037339715&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037339715&partnerID=8YFLogxK

U2 - 10.1177/001857870303800303

DO - 10.1177/001857870303800303

M3 - Review article

VL - 38

SP - 218

EP - 221

JO - Hospital Pharmacy

JF - Hospital Pharmacy

SN - 0018-5787

IS - 3

ER -